The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,953.00
Bid: 1,951.00
Ask: 1,954.00
Change: 14.00 (0.72%)
Spread: 3.00 (0.154%)
Open: 1,940.00
High: 1,956.00
Low: 1,940.00
Prev. Close: 1,939.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LIVE MARKETS-If not for Ocado...

Mon, 06th Jan 2020 11:28

* European stocks slide as U.S.-Iran tensions rise
* STOXX 600 down 1.1%, DAX -1.6%
* Airlines continue to slide on rising crude oil prices
* Risk-off: banks, chemicals, miners top fallers

Welcome to the home for real-time coverage of European equity markets brought to you by Reuters
stocks reporters and anchored today by Joice Alves. Reach her on Messenger to share your
thoughts on market moves: joice.alves.thomsonreuters.com@reuters.net

IF NOT FOR OCADO... (1127 GMT)
Europe's food retail sector would've ended 2019 in negative territory if not for Ocado's
59% jump. Food retail companies have sharply underperformed the defensive food &
beverage sector (the producers) for the past three years.
BofA says the sector is "disrupted and challenged" and believes re-rating is likely to
happen with more consolidation through M&A or procurement alliances, though not in the next 12
months.
"We expect grocers to increase their bargaining power with suppliers by building market
share. This is just a matter of time," BofA analysts add.
In the near-term, the bank prefers retailers in contential Europe to the ones in the UK,
expecting food inflation to be resilient and purchasing power to increase slightly in countries
like France, where fiscal stimulus is helping.
BofA cuts Morrisons to "underperform", while reiterating its "buy" rating on
Carrefour.
Within continental Europe, it's bearish on Metro, Jeronimo Martins and
Colruyt citing their demanding valuations and limited earnings growth.
On Ocado, BofA backs the company with a "buy" saying it offers a "full solution" for online
groceries that no other company in the business offers.



(Thyagaraju Adinarayan)
*****

BREXIT: AT LEAST ONE MORE YEAR OF PAIN? (1030 GMT)
Yes, it's going to be one more (at least) year of Brexit madness as the UK and EU negotiate
trade terms of the divorce.
Though the chances of a full-fledged trade agreement by 2020 does look slim, ING says most
trade experts reckon it would theoretically be possible to agree a basic, tariff-free agreement
covering goods trade this year.
The bank gently reminds the EU-Canada deal, which took seven years from start to finish. ING
believes if the transition period is not extended by June, then the race to get the FTA done by
2020 is uncertain.
And a failure would mean an abrupt exit from the single market and customs union for British
firms. That's another reason why ING isn't expecting a big rise in UK investment this year.
Even if the deal is struck, ING warns that a "free-trade agreement (FTA) does not
mean frictionless trade" as it would mean plenty of costs and bureaucracy.
"To qualify for zero-tariffs, UK firms selling goods to Europe will likely have to prove
that their products are sufficiently British-made. For goods that have come through a complex
supply chain, documenting the origin of a product’s value is not always easy – and often it is
simpler and cheaper to pay the tariff than it is to try and document origin," ING explains.
"Whatever happens, one thing looks fairly clear: we aren’t going to know the answer to many
of these key questions until much later in 2020."
Uncertainty over the outcome of UK-EU trade negotiations is reflected in implied volatility
gauges in sterling (chart below) which are far more elevated than for other major currencies.



(Thyagaraju Adinarayan)
*****

OPENING SNAPSHOT: BOURSES EXTEND LOSSES (0900 GMT)
European bourses opened in negative territory this morning as investors chase safe-haven
assets after tensions between the U.S. and Iran exacerbated.
The pan-European index is down 1.3%, on track for its worst day in over a month
with cyclical sectors, banking and chemical, leading the losses.
Hikma Pharmaceuticals and Covestro shares are down more than 5%.
Britain's blue-chip index is down 0.8%. Morrison shares slide 3.7% after and
BofA downgrade and German rival Aldi reported strong sales in the UK.
Here is your snapshot of European bourses almost one hour from the open.
(Joice Alves)
*****

ON OUR RADAR: ATLANTIA AND RETAILERS (0757 GMT)
Futures point to a lower open in Europe this morning as investors are betting on safer
assets such as gold amid escalating Middle East tensions.
In Italy, shares of Atlantia are under pressure after the CEO of the company's unit
Autostrade told a local paper that the unit risks going bankrupt if Italy's government revokes
its motorway licence with limited compensation.
It is a public holiday in Milan but the stock exchange will be trading regular hours.
Christmas festivities gave a boost to the British arm of Aldi , with total sales
rising 7.9% in the four weeks to Dec. 24 year-on-year, driven by strong growth in beers, wines
and spirits as well as its premium ranges.
Good news also for German retailers as sales across the country was up 2.1% m/m and +2.8%
y/y in November, Germany statistics office said today.
In terms of macro news, UK, Spain, France, Germany and Italy are releasing PMI data this
morning.
On the M&A front, Covivio Hotels signed an agreement to acquire a portfolio of eight hotels
located in Rome, Florence, Venice, as well as in Nice, Prague and Budapest for €573 million
including capex..

Other corporate headlines this morning:
S.Korean restaurant owners voice concerns over $4 bln Delivery Hero deal
Ternienergia Signs Preliminary Contract With Buttol Srl For Sale Of Biodigestion &Biomethane
Production Plant

(Joice Alves)
*****



EPIPHANY CELEBRATIONS HIT BY MIDDLE EAST TENSIONS (0650 GMT)
European bourses are seen opening lower this morning as the escalating U.S.-Iran tensions
are prompting investors to bet on safe assets.
Gold surged close to a seven-year peak today, as investors flocked to the safe-haven metal,
while palladium surpassed the level of $2,000 to hit a record high.
Helsinki and Warsaw stock exchanges will be shut today for the Epiphany holiday. In Milan
and Madrid, the public holiday won't affect trading hours.
Financial spreadbetters at IG expect London's FTSE to open 42 points lower at 7,580,
Frankfurt's DAX to open 124 points lower at 13,095, and Paris' CAC to open 59 points lower at
5,985.

(Joice Alves)
*****



(Reporting by Danilo Masoni, Joice Alves, Julien Ponthus and Thyagaraju Adinarayan)

More News
17 Jan 2022 09:01

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 09:00

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 07:49

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

Read more
17 Jan 2022 07:08

Hikma buys Teligent Canadian assets for $47.75m

(Sharecast News) - Hikma Pharmaceuticals on Monday said it had agreed to buy the Canadian assets of Teligent for $45.75m after the US firm filed for Chapter 11 bankruptcy last year.

Read more
10 Jan 2022 07:44

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

Read more
10 Jan 2022 07:24

Hikma launches new US injectables unit

(Sharecast News) - Hikma Pharmaceuticals on Monday said it was expanding its injectables business with the launch of a new outsourced sterile compounding business in the US.

Read more
21 Dec 2021 15:55

Arecor flags milestone payment from Hikma in first half of next year

(Sharecast News) - Biopharmaceutical company Arecor Therapeutics updated the market on its ongoing exclusive agreement with Hikma Pharmaceuticals to co-develop a new, ready-to-use injectable medicine on Tuesday.

Read more
9 Dec 2021 09:25

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Read more
9 Dec 2021 08:32

Hikma strikes exclusive license agreement with Richter for denosumab

(Sharecast News) - Drugmaker Hikma Pharmaceuticals has entered into an exclusive license agreement with Gedeon Richter to commercialise the latter's denosumab products in the US.

Read more
4 Nov 2021 09:03

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

Read more
4 Nov 2021 07:58

Hikma reports solid trading in year to date

(Sharecast News) - Hikma Pharmaceuticals reiterated full-year guidance as the company reported solid trading across its business.

Read more
1 Nov 2021 13:52

Citi sees room for upside surprise on sales at Hikma Pharmaceuticals

(Sharecast News) - Analysts at Citi reiterated their 'buy' stance for shares of Hikma Pharmaceuticals ahead of the company's trading statement due out later in the same week.

Read more
28 Oct 2021 16:12

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
20 Oct 2021 09:51

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

Read more
27 Sep 2021 12:14

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.